Decentralized clinical trials - A more patient-centric approach
Decentralized clinical trials, where portions of a study are conducted outside a traditional trial site, offer new opportunities — and new hope — for patients struggling with inflammatory conditions.
Related Insights
Blog
Including patients in DCT design
Sep 13, 2022
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Video
The 2024 FDA Diversity Guidance Update: What does it mean for patients, sites, sponsors and CROs
Aug 22, 2024
Article
Australia: Infrastructure and Innovations for Clinical Trials
Aug 28, 2023
Podcast
Enabling Successful Sites, Ep2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Blog
Best practices and lessons learned in a challenging IBD study
Jul 19, 2023
Report
New Medicines, Novel Insights: Achieving patient-guided drug development
Oct 30, 2023
Blog
Decentralized Trials: Considerations for Building a New Patient-Centric Model
May 13, 2021
Video
The FDAs Race and Ethnic Diversity Plan Guidance: How prepared is your organization?
Feb 1, 2023
Blog
Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression
Apr 23, 2024
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Blog
A patient-centric approach to managing clinical trial complexity
Jul 13, 2021
Related Insights
Blog
Including patients in DCT design
Sep 13, 2022
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Video
The 2024 FDA Diversity Guidance Update: What does it mean for patients, sites, sponsors and CROs
Aug 22, 2024
Article
Australia: Infrastructure and Innovations for Clinical Trials
Aug 28, 2023
Podcast
Enabling Successful Sites, Ep2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Blog
Best practices and lessons learned in a challenging IBD study
Jul 19, 2023
Report
New Medicines, Novel Insights: Achieving patient-guided drug development
Oct 30, 2023
Blog
Decentralized Trials: Considerations for Building a New Patient-Centric Model
May 13, 2021
Video
The FDAs Race and Ethnic Diversity Plan Guidance: How prepared is your organization?
Feb 1, 2023
Blog
Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression
Apr 23, 2024
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Blog
A patient-centric approach to managing clinical trial complexity
Jul 13, 2021